TABLE 1.
CMY-2 variants | ||||||||
---|---|---|---|---|---|---|---|---|
Substrate | Kinetics parameters | Without mutation (CMY-2) | V211S (CMY-42) | N346Y | A114E_N346Y | Q120K_N346Y | V211S_N346Y | A114E_Q120K_ V211S_N346Y (CMY-185) |
Nitrocefin | ||||||||
kcat (s−1) | 2.4 × 102 ± 0.5 × 102 | 3.2 × 102 ± 1.02 × 102 | 61 ± 5 | 57 ± 10 | 1.2 × 102 ± 0.9 × 102 | 85 ± 18 | 17 ± 9 | |
Km (µM) | 17 ± 5 | 29 ± 12 | 25 ± 3 | 16 ± 4 | 50 ± 40 | 35 ± 10 | 39 ± 24 | |
Ki (µM) | 1.6 × 102 ± 1.0 × 102 | 1.3 × 102 ± 0.7 × 102 | 87 ± 25 | 68 ± 37 | 14 ± 12 | 1.0 × 102 ± 0.5 × 102 | 18 ± 13 | |
kcat/Km (µM−1 s−1) | 14 ± 5 | 11 ± 5 | 2.5 ± 0.4 | 3.6 ± 1.2 | 2.4 ± 2.5 | 2.4 ± 0.9 | 0.4 ± 0.4 | |
Cephalothin | ||||||||
kcat (s−1) | 54 ± 0.8 | 83 ± 7 | 18 ± 7 | 3.3 ± 0.1 | 42 ± 5 | 9.6 ± 0.2 | 14 ± 1 | |
Km (µM) | 4.1 ± 0.3 | 7.5 ± 1.1 | 3.9 ± 0.1 | 1.4 ± 0.1 | 18 ± 3 | 4.4 ± 0.3 | 19 ± 1 | |
kcat/Km (µM−1 s−1) | 13 ± 1 | 11 ± 2 | 4.7 ± 1.8 | 2.3 ± 0.2 | 2.4 ± 0.5 | 2.2 ± 0.2 | 0.8 ± 0.1 | |
Ceftazidime | ||||||||
kcat (s−1) | N.D. | 1.5 ± 0.2 | N.D. | N.D. | 7.7 × 10−2 ± 0.3 × 10−2 | 0.3 ± 0.0 | 0.1 ± 0.0 | |
Km (µM) | N.M. | 74 ± 10 | N.M. | N.M. | 5.3 ± 0.5 | 37 ± 2 | 2.2 ± 0.3 | |
Ki app (µM) | 0.7 ± 0.1 | N.M. | 0.7 ± 0.2 | 0.3 ± 0.0 | N.M. | N.M. | N.M. | |
kcat/Km (µM−1 s−1) | N.C. | 2.0 × 10−2 ± 0.3 × 10−2 | N.C. | N.C. | 1.5 × 10−2 ± 0.2 × 10−2 | 9.0 × 10−3 ± 0.7 × 10−3 | 5.3 × 10−2 ± 0.7 × 10−2 | |
Cefiderocol | ||||||||
kcat (s−1) | N.D. | 3.4 × 10−2 ± 0.2 × 10−2 | N.D. | N.D. | N.D. | 4.9 × 10−2 ± 0.3 × 10−2 | 6.9 × 10−3 ± 0.4 ×10−3 a | |
Km (µM) | N.M. | 68 ± 11 | N.M. | N.M. | N.M. | 6.9 ± 1.5 | N.M. | |
Ki app (µM) | 8.0 ± 1.3 | N.M. | 0.7 ± 0.0 | 0.4 ± 0.0 | 0.4 ± 0.0 | N.M. | 0.2 ± 0.0 | |
kcat/Km (µM−1 s−1) | N.C. | 4.9 × 10−4 ± 0.9 × 10−4 | N.C. | N.C. | N.C. | 7.1 × 10−3 ± 1.6 × 10−3 | 3.0 × 10−2 ± 0.2 × 10−2 b | |
Avibactam | ||||||||
Ki app (µM) | 6.3 × 10−2 ± 1.2 × 10−2 | 3.4 × 10−2 ± 0.6 × 10−2 | 41 ± 6 | 80 ± 9 | 5.9 × 102 ± 0.2 × 102 | 14 ± 4 | 1.3 × 103 ± 0.1 × 103 | |
k2/K (M−1 s−1) | 2.8 × 104 ± 0.1 × 104 | 2.3 × 104 ± 0.1 × 104 | 59 ± 6 | 41 ± 0.4 | 32 ± 0.4 | 66 ± 6 | 7.4 ± 0.3 | |
k−2 (s−1) | 1.2 × 10−4 ± 0.2 × 10−4 | 1.5 × 10−4 ± 0.2 × 10−4 | 1 × 10−5 ± 16 × 10−5 | 1.1 × 10−4 ± 0.0 × 10−4 | 2.0 × 10−3 ± 0.1 × 10−3 | 4.4 × 10−4 ± 2.1 × 10−4 | 7.0 × 10−4 ± 0.5 × 10−4 | |
koff (s−1) | 7.3 × 10−5 ± 0.0 × 10−5 | 6.0 × 10−5 ± 0.0 × 10−5 | 2.6 × 10−6 ± 0.0 × 10−6 | 9.0 × 10−7 ± 0.0 × 10−7 | 4.0 × 10−6 ± 0.0 ×10−6 | 2.4 × 10−6 ± 0.0 × 10−6 | 4.8 × 10−7 ± 0.0 × 10−7 |
Due to the small Km value of CMY-185 for cefiderocol, the kcat value was determined with the measured velocities at the steady state (cefiderocol concentration range: 3.7–59.4 µM) and the Ki app value assumed to Km.
The kcat/Ki app value is shown.
The values are the mean ± standard error of three independent measurements. N.M. = not measured; N.D. = not detected; N.C. = not calculated.